[HTML][HTML] Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

G Suntharalingam, MR Perry, S Ward… - … England Journal of …, 2006 - Mass Medical Soc
<p id="p001">Six healthy young male volunteers at a contract research organization were
enrolled in the first phase 1 clinical trial of TGN1412, a novel superagonist anti-CD28 …

Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis

MR Perry, S Wyllie, A Raab… - Proceedings of the …, 2013 - National Acad Sciences
The Indian subcontinent is the only region where arsenic contamination of drinking water
coexists with widespread resistance to antimonial drugs that are used to treat the parasitic …

Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown

…, S Zhao, RNR Cave, MR Perry… - … of the Royal …, 2021 - royalsocietypublishing.org
This study demonstrates that an adoption of a segmenting and shielding strategy could increase
the scope to partially exit COVID-19 lockdown while limiting the risk of an overwhelming …

The R Enantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis

…, S Wyllie, L Stojanovski, MR Perry… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The novel nitroimidazopyran agent (S)-PA-824 has potent antibacterial activity against
Mycobacterium tuberculosis in vitro and in vivo and is currently in phase II clinical trials for …

[HTML][HTML] Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study

MR Perry, VK Prajapati, J Menten, A Raab… - PLoS neglected …, 2015 - journals.plos.org
Background In the late twentieth century, emergence of high rates of treatment failure with
antimonial compounds (SSG) for visceral leishmaniasis (VL) caused a public health crisis in …

[HTML][HTML] Secrets of the hospital underbelly: patterns of abundance of antimicrobial resistance genes in hospital wastewater vary by specific antimicrobial and bacterial …

MR Perry, HC Lepper, L McNally, BA Wee… - Frontiers in …, 2021 - frontiersin.org
Background: Hospital wastewater is a major source of antimicrobial resistance (AMR) outflow
into the environment. This study uses metagenomics to study how hospital clinical activity …

[HTML][HTML] Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?

MR Perry, S Wyllie, VK Prajapati… - PLoS neglected …, 2011 - journals.plos.org
Antimony and arsenic are elements that have a long history of use as poisons, therapeutic
agents, or cosmetics. For over a century, compounds containing pentavalent antimony (…

[HTML][HTML] Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities

S Zhao, S Kennedy, MR Perry, J Wilson… - Journal of Hospital …, 2021 - Elsevier
Background Carbapenemase-producing organisms (CPO) have been largely responsible
for the extensive spread of carbapenem resistance, and their prevalence is increasing in …

[HTML][HTML] Distinctive hospital and community resistomes in Scottish urban wastewater: Metagenomics of a paired wastewater sampling design

HC Lepper, MR Perry, BA Wee, D Wills… - Science of the Total …, 2023 - Elsevier
The wastewater microbiome contains a multitude of resistant bacteria of human origin,
presenting an opportunity for surveillance of resistance in the general population. However, …

Focussing on resistance to front-line drugs is the most effective way to combat the antimicrobial resistance crisis

MR Perry, D McClean, C Simonet, M Woolhouse… - BioRxiv, 2018 - biorxiv.org
In medical, scientific and political arenas relating to antimicrobial resistance (AMR) there is
currently an intense focus on multi-drug resistant pathogens that render last-line antimicrobial …